PQ 280
280. Deputy Pádraig Mac Lochlainn asked the Minister for Health if his attention has been drawn to the ongoing frustration of a group (details supplied) not to recommend in favour of reimbursement of patisiran for the treatment of hereditary transthyretin-mediated hATTRA amyloidosis here; and the reason this drug is available to patients in Northern Ireland but not here. [7688/21]
Introduced
11 February 2021
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
11 February 2021
Summary
280. Deputy Pádraig Mac Lochlainn asked the Minister for Health if his attention has been drawn to the ongoing frustration of a group (details supplied) not to recommend in favour of reimbursement of patisiran for the treatment of hereditary transthyretin-mediated hATTRA amyloidosis here; and the reason this drug is available to patients in Northern Ireland but not here. [7688/21]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 11 February 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2021-02-11/280/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2021-02-11/pq_280